FREQUENTLY ENCOUNTERED INQUIRIES What is BPC-157 and how does it work
2014 follow-up study was retracted in 2025, which means the foundational evidence base has significant integrity concerns that should be weighed carefully
'fb_in_app_browser_popup } 'in_app_browser_popup } item(s)) Not enough stock
Semaglutide is a GLP-1 receptor agonist that mimics the GLP-1 hormone - slowing gastric emptying, reducing appetite, triggering glucose-dependent insulin release, and suppressing glucagon
In India, where access is unequal, who should get priority?From a public health perspective, priority should go to patients with clear medical benefit, such as diabetics with existing cardiovascular disease, high-risk diabetics with multiple risk factors, and those with obesity-related heart failure
Eat before drinking: Having food in your system helps slow alcohol absorption and reduces blood sugar fluctuations